BioSpace News Archive

Company to Accelerate International Expansion and Further Investments in AI, Machine Learning, and Digital Clinical Trials

Transition to INM-755 Expected to Improve the Probability of Development and Regulatory Success

Leading market research firm recognizes exceptional customer service

Eiger BioPharmaceuticals, Inc. announced a late-breaker oral presentation of Phase 2 LIMT HDV end of study 24 week post-treatment results will be presented at The International Liver Congress™ 2019 in Vienna, Austria, April 10 to 13.

Pall Corporation, a global leader in filtration, separation and purification, announced the next step in the collaboration agreement with ARTeSYN® Biosolutions, a leading innovator in single-use components and fluid management technologies.

Sekhmet Ventures, a newly-formed venture capital firm in the beauty and wellness market, announced the appointment of Sara Kaur as its Chief Financial Officer.

Former Goldman Sachs Managing Director Andrew Pucher joins Tilray to lead the company’s global corporate development activity, including M&A and corporate investments

Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview at Oppenheimer’s 29th Annual Healthcare Conference on March 20, 2019 at 8:00am ET at the Westin New York Grand Central Hotel in New York City, NY.

BioInvent International AB announces that the United States Patent and Trademark Office has issued a Notice of Allowance, informing the company that a patent application relevant to its F.I.R.S.T.™ platform has been allowed and can proceed to grant.

Stone Oak Orthodontics, home of one of the nation’s top orthodontists, Dr. Robert “Tito” Norris, announced the grand opening of its second orthodontic location near the Dominion, Texas on Friday, March 15, 2019.